Additionally, CD8+ Tregs are also able to inhibit the proliferation and effector function of effector lymphocytes,12 and they have drawn increased attention for treating autoimmune diseases.13, 14, 15 Interestingly, the subsets of CD8+ Tregs in each study are somewhat different. Here, CD8A is linked to autoimmune disease.